Bitcoin Traders Blame Saylor’s 32-BTC Sale, Market Pressure
A tiny 32 BTC sale by Saylor’s firm coincides with a wider pullback driven by major treasury holders and miner liquid...
Why Active Funds May Underperform Benchmarks
Why Active Funds May Underperform Benchmarks discusses persistent headwinds, costs, and timing issues that hinder outperformance.
26,804 articles
CFPB Guidance Points Mortgage: Immigration Status
The CFPB signals that immigration status could influence a borrower's ability to repay a loan, potentially reshaping ...
Arteris Director Sold Over 20,000 Shares: What It Means
A director at Arteris disclosed disposing over 20,000 shares, split between a gift and an open-market sale. Here’s ho...
Mortgage Lock Volume Slid in May as Rates Rise and Cools
May 2026 data show mortgage lock volume slid 9% from April as higher rates cooled demand. Purchases led the market, w...
Have Until 2031: What Happens to Loans and Housing
A quiet demographic trend could reshape the loan landscape by 2031. This article explains what to expect for mortgage...
Semtech Stock Sell After COO Sale: Investor Readiness
When an executive sells stock, investors ask whether it signals trouble or simply personal liquidity needs. This guid...
Mortgage with Class-Action Suit Over May 2025 Breach
A former employee has filed a class-action complaint against US Mortgage Corp. over a May 2025 data breach that expos...
Top AI Healthcare Stock Hold Forever: Why ISRG Is the Pick
Healthcare costs loom large for retirees and investors alike. This article argues that one AI-driven healthcare leade...
NVIDIA Leads the Artificial Intelligence (AI) Inference Market
As the AI boom accelerates, the inference layer becomes the engine. This article explains why artificial intelligence...
Analyst Price Targets SpaceX: Eye-Popping Estimates Emerge
Analyst price targets SpaceX have sparked a heated debate among investors. This guide explains how targets are built,...
Why CoreWeave Stock Keeps Falling: Debt Costs Weigh Growth Plans
CoreWeave is expanding fast on the AI cloud frontier, but heavy borrowing and rising interest expenses are pulling th...
XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status